Mainz Biomed N.V.
MYNZ
$1.59
-$0.02-1.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | 24.31% | 24.31% | -2.51% | 33.20% | |
| Total Depreciation and Amortization | 0.60% | 0.60% | 27.14% | 45.32% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -16.30% | -16.30% | 899.32% | -27.17% | |
| Change in Net Operating Assets | -117.00% | -117.00% | -229.56% | -81.44% | |
| Cash from Operations | 20.00% | 20.00% | 3.92% | 20.44% | |
| Capital Expenditure | 99.00% | 99.00% | 104.88% | 51.21% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -50.00% | -50.00% | 175.00% | -- | |
| Cash from Investing | -7.28% | -7.28% | 142.36% | -70.15% | |
| Total Debt Issued | -- | -- | -- | -70.65% | |
| Total Debt Repaid | 7.99% | 7.99% | 73.82% | -85.10% | |
| Issuance of Common Stock | 586.10% | 586.10% | 47.23% | -57.87% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 4.86% | 4.86% | 102.67% | -76.46% | |
| Foreign Exchange rate Adjustments | 58.48% | 58.48% | 95.80% | 68.09% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 29.03% | 29.03% | 216.87% | -5,859.17% | |